NOC/C: for the treatment of patients with transfusion-dependent anemia due to myelodysplastic syndrome.
It may only be given to patients who had registered and meet all conditions of the RevAid program.
RevAid is a controlled distribution program for this drug to minimize the risk of fetal exposure, as lenalidomide is structurally similar to thalidomide. Physicians and pharmacists must be registered and meet all the conditions of the program. Additional information can be obtained from www.revaid.ca or 1-888-738-2431.